Patents Assigned to E5 Pharma LLC
  • Long acting dual release product containing carbinoxamine and pseudoephedrine
    Patent number: 9339471
    Abstract: Provided are oral dosage forms that contain carbinoxamine in an immediate release format, and pseudoephedrine in a prolonged release format. The biphasic oral dosage forms may also contain other active ingredients in combination with carbinoxamine, including other decongestants, antitussives, analgesics and expectorants.
    Type: Grant
    Filed: March 15, 2013
    Date of Patent: May 17, 2016
    Assignee: E5 PHARMA, LLC
    Inventors: Robert J. Edwards, Chih-Ting Huang, Nam-Mew Pui
  • Long acting dual release product containing carbinoxamine and pseudoephedrine
    Patent number: 8450349
    Abstract: Provided are oral dosage forms that contain carbinoxamine in an immediate release format, and pseudoephedrine in a prolonged release format. The biphasic oral dosage forms may also contain other active ingredients in combination with carbinoxamine, including other decongestants, antitussives, analgesics and expectorants.
    Type: Grant
    Filed: September 11, 2008
    Date of Patent: May 28, 2013
    Assignee: E5 Pharma LLC
    Inventors: Robert J. Edwards, Jr., Chih-Ting Huang, Nam-Mew Pui